-
Steroids Not Linked to Risk of Fractures; ADT Puts Men at Risk for Osteoporosis; Study Shows Valsartan May Improve Sexual Function in Postmenopausal Women; New Direct-to-Consumer Pharma Advertising Rules Considered; FDA Actions
-
-
In this second part of our two-part series, the SCMARTI (Selection of Cephalosporins, Macrolides, and AFQs for Respiratory Tract Infections) Consensus Panel presents recommendations for antimicrobial therapy in acute bacterial exacerbations of chronic bronchitis, along with a comprehensive treatment table to guide therapy in the emergency department and outpatient setting.
-
A consensus group making recommendations on the use of restraining therapies in the ICU emphasizes the inadequacy of the evidence base in this area and calls for studies to generate better data.
-
This single-center study reveals that, compared to continuous sedation, daily sedative interruption is not associated with adverse psychological effects after 6-21 months.
-
Adult patients presenting with acute asthma without significant respiratory acidosis who were given 100% oxygen to breathe had slight increases in arterial PCO2 and slight decreases in arterial pH and peak expiratory flow, as compared with patients who received only 28% oxygen.
-
In late-onset VAP, survival improved and costs decreased using initial coverage with 3 antibiotics. Mini-BAL did not improve survival but decreased costs and antibiotic usage.
-
-
Part I of this two-part series on respiratory diseases covered two viral infections, severe acute respiratory syndrome and influenza. Part II focuses on a bacterial infection, community-acquired pneumonia.
-
Emergency Medicine Reports received a 2004 First Place award in the Best Single-Topic Newsletter category from the Newsletter and Electronic Publishers Foundation for the two-part article on immigrant medicine published Feb. 10 and Feb. 24, 2003. The authors of the winning article are Mary Meyer, MD, Danica Barron, MD, and Carter Clements, MD. The article was edited by Gideon Bosker, MD, and Shelly Morrow Mark.